The Board Adopted the Audited standalone Financial Results for the Quarter and Financial Year ended as on 31st March 2025 along with report of statutory auditors and Declaration pursuant ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.3 pts more than Nifty Microcap 250 and 3.8 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board approved audited standalone results for Q4 FY25 and full year FY25 along with a clean (unmodified) audit report from M/s Suresh R. Shah & Associates. Revenue from operations jumped about 42% YoY to Rs 4,993.54 lakh (vs Rs 3,518.71 lakh in FY24), driven by higher material costs. Profit after tax rose to Rs 30.22 lakh from Rs 21.60 lakh, a growth of roughly 40%, and basic EPS improved to Rs 3.36 from Rs 2.40. However, Q4 standalone PAT was weak at just Rs 2.77 lakh versus Rs 23.19 lakh in Q4 FY24, dragged down by higher depreciation and finance charges. Total debt stood at about Rs 1,084 lakh against equity of Rs 403 lakh, keeping the debt-to-equity ratio elevated near 2.7x, and finance costs of Rs 85.24 lakh consumed most of the operating profit.
Annual revenue and profit growth are positive signals, but the sharp drop in Q4 PAT and very high leverage mean the earnings quality remains weak and debt servicing is heavy. Shareholders should expect muted short-term price reaction despite topline growth.